Pulse Biosciences rises after submitting marketing application for medical device

Pulse Biosciences

21/11/2023 19:21

** Shares of medical device maker Pulse Biosciences  PLSE.O 
rise as much as 18.4% to a near three-month high of $7.4; last
up 7% in afternoon trade
    ** Co submits a marketing application to the U.S. FDA for
medical device CellFX nsPFA, which is developed with its
proprietary technology that uses non-thermal energy to destroy
cellular tissue while sparing adjacent non-cellular tissue 
    ** Co is seeking approval of the device for non-cardiac use
    ** FDA completes review of marketing application for medical
devices within 90 days
    ** Shares trading well above their 200-day moving avg. of
$5.34
    ** Including session's gain, stock has more than doubled YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))